EML4-ALK: A New Molecular Target in NSCLC

For physicians and healthcare professionals who value the highest standards of clinical care, the Massachusetts General Hospital Academy provides world-renowned education that improves clinical practice and leads to better lives for patients and their families. Advanced teaching methods, an interactive learning format, and focus on solving real-world, practice-related challenges give the Academy international recognition for helping providers effectively diagnose and treat their patients across a variety of therapeutic areas.

Share EML4-ALK: A New Molecular Target in NSCLC

Sign up to save your podcasts

EML4-ALK: A New Molecular Target in NSCLC

EML4-ALK: A New Molecular Target in NSCLC